FAM
Fred Alger Management Portfolio holdings
AUM
$22.3B
1-Year Return
57.87%
This Quarter Return
+17.72%
1 Year Return
+57.87%
3 Year Return
+264.72%
5 Year Return
+406.03%
10 Year Return
+1,631.73%
AUM
$18.5B
AUM Growth
+$1.14B
(+6.5%)
Cap. Flow
-$1.34B
Cap. Flow
% of AUM
-7.21%
Top 10 Holdings %
Top 10 Hldgs %
39.28%
Holding
503
New
41
Increased
140
Reduced
229
Closed
60
Top Buys
| 1 |
Advanced Micro Devices
AMD
|
$108M |
| 2 |
Amgen
AMGN
|
$96.3M |
| 3 |
Broadcom
AVGO
|
$92.2M |
| 4 |
Vertiv
VRT
|
$86.5M |
| 5 |
Burlington
BURL
|
$55.8M |
Top Sells
| 1 |
NVIDIA
NVDA
|
$152M |
| 2 |
Trip.com Group
TCOM
|
$107M |
| 3 |
Tesla
TSLA
|
$91.5M |
| 4 |
PXD
Pioneer Natural Resource Co.
PXD
|
$79.8M |
| 5 |
Trade Desk
TTD
|
$78.5M |
Sector Composition
| 1 | Technology | 37.44% |
| 2 | Healthcare | 19.58% |
| 3 | Consumer Discretionary | 11.08% |
| 4 | Industrials | 10.46% |
| 5 | Communication Services | 10.2% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
326
Akero Therapeutics
AKRO
$3.58B
| $2.12M | 0.01% |
90,812
-350,274
| -79% | -$8.18M |
|
327
HilleVax
HLVX
$105M
| $2.11M | 0.01% |
131,447
+10,813
| +9% | +$174K |
|
328
Johnson Controls International
JCI
$69.5B
| $2.09M | 0.01% |
36,340
+2,238
| +7% | +$129K |
|
329
Bristol-Myers Squibb
BMY
$96B
| $2.08M | 0.01% |
40,530
+305
| +0.8% | +$15.7K |
|
330
CyberArk
CYBR
$23.3B
| $2.06M | 0.01% |
9,382
+26
| +0.3% | +$5.7K |
|
331
Privia Health
PRVA
$2.86B
| $2.05M | 0.01% |
88,877
-917
| -1% | -$21.1K |
|
332
Global Payments
GPN
$21.3B
| $2.03M | 0.01% |
15,998
-3,190
| -17% | -$405K |
|
333
Vail Resorts
MTN
$5.87B
| $2.01M | 0.01% |
9,438
| – | – |
|
334
Teleflex
TFX
$5.78B
| $1.95M | 0.01% |
7,804
-12,605
| -62% | -$3.14M |
|
335
Blackstone Mortgage Trust
BXMT
$3.45B
| $1.93M | 0.01% |
90,670
+7,124
| +9% | +$152K |
|
336
Elanco Animal Health
ELAN
$9.16B
| $1.92M | 0.01% |
129,077
-491,787
| -79% | -$7.33M |
|
337
MaxCyte
MXCT
$150M
| $1.91M | 0.01% |
407,096
+46,222
| +13% | +$217K |
|
|
MORF
338
DELISTED
Morphic Holding, Inc. Common Stock
MORF
| $1.9M | 0.01% |
65,649
-67,096
| -51% | -$1.94M |
|
339
Gilead Sciences
GILD
$143B
| $1.78M | 0.01% |
22,003
+1,165
| +6% | +$94.4K |
|
340
Cytokinetics
CYTK
$6.34B
| $1.75M | 0.01% |
+20,921
| New | +$1.75M |
|
341
Oscar Health
OSCR
$5.02B
| $1.73M | 0.01% |
189,307
+21,675
| +13% | +$198K |
|
342
Salesforce
CRM
$239B
| $1.67M | 0.01% |
6,348
-705
| -10% | -$186K |
|
343
General Dynamics
GD
$86.8B
| $1.66M | 0.01% |
6,410
+61
| +1% | +$15.8K |
|
344
WillScot Mobile Mini Holdings
WSC
$4.32B
| $1.65M | 0.01% |
37,139
-114,668
| -76% | -$5.1M |
|
345
CAVA Group
CAVA
$7.73B
| $1.63M | 0.01% |
37,833
-469
| -1% | -$20.2K |
|
|
MRTX
346
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $1.58M | 0.01% |
+26,977
| New | +$1.58M |
|
347
Rivian
RIVN
$17.2B
| $1.52M | 0.01% |
64,713
-302,613
| -82% | -$7.1M |
|
348
Forte Biosciences
FBRX
$140M
| $1.51M | 0.01% |
73,559
| – | – |
|
349
Masimo
MASI
$8B
| $1.46M | 0.01% |
+12,439
| New | +$1.46M |
|
350
XPO
XPO
$15.4B
| $1.44M | 0.01% |
16,447
-3,188
| -16% | -$279K |
|